{"title":"格列齐特MV:已证实的有效性和安全性","authors":"E. Ivannikova, E. Dudinskaya","doi":"10.33978/2307-3586-2023-19-1-32-38","DOIUrl":null,"url":null,"abstract":"To date, sulfonylurea derivatives occupy a leading position in the structure of diabetes mellitus therapy. The article discusses the effectiveness and safety of the use of sulfonylurea derivatives in order to compensate for carbohydrate metabolism, including in comparison with other classes of hypoglycemic drugs. Special emphasis is placed on cardiovascular safety.","PeriodicalId":11400,"journal":{"name":"Effective Pharmacotherapy","volume":"207 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Gliclazide MV: Proven Efficacy and Safety\",\"authors\":\"E. Ivannikova, E. Dudinskaya\",\"doi\":\"10.33978/2307-3586-2023-19-1-32-38\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"To date, sulfonylurea derivatives occupy a leading position in the structure of diabetes mellitus therapy. The article discusses the effectiveness and safety of the use of sulfonylurea derivatives in order to compensate for carbohydrate metabolism, including in comparison with other classes of hypoglycemic drugs. Special emphasis is placed on cardiovascular safety.\",\"PeriodicalId\":11400,\"journal\":{\"name\":\"Effective Pharmacotherapy\",\"volume\":\"207 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-03-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Effective Pharmacotherapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33978/2307-3586-2023-19-1-32-38\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Effective Pharmacotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33978/2307-3586-2023-19-1-32-38","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
To date, sulfonylurea derivatives occupy a leading position in the structure of diabetes mellitus therapy. The article discusses the effectiveness and safety of the use of sulfonylurea derivatives in order to compensate for carbohydrate metabolism, including in comparison with other classes of hypoglycemic drugs. Special emphasis is placed on cardiovascular safety.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
